At VETA, we leverage silico modeling, a sophisticated computational technique that explores interactions between macromolecules (typically proteins) and ligands (such as drug molecules). This technology enables us to predict how ligands bind to receptors, providing valuable insights into binding affinity, orientation, and other critical properties. This method forms the foundation of our product discovery process, allowing us to develop highly effective and targeted solutions.


In addition to silico modeling, we incorporate artificial intelligence (AI) to accelerate product design and efficacy testing. Our AI-driven approach ensures precision in nutrition and health product discovery, leading to faster development cycles and more effective outcomes.